Detalhe da pesquisa
1.
Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial.
JAMA
; 320(20): 2099-2107, 2018 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30357270
2.
Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial.
JAMA
; 314(16): 1711-9, 2015 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26444879